GAD2 and type 1 diabetes mellitus: According to ECL analysis, ECL-GAD65 antibody-positive participants resemble type 1 diabetes patients with slender body size and poor β-cell function, whereas ECL-GAD65 antibody-negative patients have a similar phenotype to type 2 diabetes individuals with good β-cell mass and a slow rate of insulin insufficiency (74).